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Abstract
Burkholderia cenocepacia J2315 is representative of a highly problematic group of cystic fibrosis (CF) pathogens. Eradication
of B. cenocepacia is very difficult with the antimicrobial therapy being ineffective due to its high resistance to clinically
relevant antimicrobial agents and disinfectants. RND (Resistance-Nodulation-Cell Division) efflux pumps are known to be
among the mediators of multidrug resistance in Gram-negative bacteria. Since the significance of the 16 RND efflux systems
present in B. cenocepacia (named RND-1 to -16) has been only partially determined, the aim of this work was to analyze
mutants of B. cenocepacia strain J2315 impaired in RND-4 and RND-9 efflux systems, and assess their role in the efflux of
toxic compounds. The transcriptomes of mutants deleted individually in RND-4 and RND-9 (named D4 and D9), and a
double-mutant in both efflux pumps (named D4-D9), were compared to that of the wild-type B. cenocepacia using
microarray analysis. Microarray data were confirmed by qRT-PCR, phenotypic experiments, and by Phenotype MicroArray
analysis. The data revealed that RND-4 made a significant contribution to the antibiotic resistance of B. cenocepacia, whereas
RND-9 was only marginally involved in this process. Moreover, the double mutant D4-D9 showed a phenotype and an
expression profile similar to D4. The microarray data showed that motility and chemotaxis-related genes appeared to be up-
regulated in both D4 and D4–D9 strains. In contrast, these gene sets were down-regulated or expressed at levels similar to
J2315 in the D9 mutant. Biofilm production was enhanced in all mutants. Overall, these results indicate that in B.
cenocepacia RND pumps play a wider role than just in drug resistance, influencing additional phenotypic traits important for
pathogenesis.
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Introduction
The Burkholderia cepacia complex (Bcc) constitutes a group of
phenotypically similar non-fermenting, aerobic, Gram-negative
rods that infect 2 to 8% of patients with cystic fibrosis (CF) [1].
Bcc comprises at least 17 different closely related species whose
correct identification is particularly important in clinical microbi-
ology as these bacteria are opportunistic pathogens that can cause
severe lung infections in immuno-compromised as well as in CF
patients [1].
In CF patients, antibiotics are used to clear early infection, treat
acute exacerbations of chronic infection and reduce their relapse
frequency. These treatments have had a major impact on the
quality and survival of CF patients [2]. Despite the heavy use of
antibiotics in CF, over the last decades, B. cenocepacia has emerged
as an important respiratory pathogen in the CF community.
Pulmonary colonization/infection by this bacterium may persist
for months or even years but a minority of patients exhibits a rapid
clinical deterioration associated with severe respiratory inflamma-
tion, epithelial necrosis and invasive disease, a condition known as
cepacia syndrome [3,4].
The B. cenocepacia epidemic ET12 lineage that originated in
Canada and spread to Europe has been one of the most prevalent
Bcc genotypes isolated from CF patients, with strain J2315 being
studied in depth as model isolate [5]. The 8.06-Mb genome of this
highly transmissible pathogen, consisting of three circular
chromosomes and a plasmid, encodes a broad array of functions
typical of metabolically versatile genus Burkholderia, as well as
several virulence and drug resistance functions [5]. Antimicrobial
therapy for Bcc is often ineffective as members of the B. cepacia
complex are highly resistant to most clinically relevant antimicro-
bial agents and disinfectants [6]. Multi-drug resistance (MDR) in
CF isolates is defined as resistance to all of the agents belonging to
at least two of three classes of antibiotics, such as quinolones,
aminoglycosides, and b-lactam agents, including monobactams
and carbapenems [7].
Particularly interesting among mediators of MDR in Gram-
negative bacteria are transporters belonging to the RND
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catalyze the active efflux of many antibiotics and chemotherapeu-
tic agents [8]. RND transporters are protein complexes that span
both the cytoplasmic and outer membrane. The complex
comprises a cytoplasmic membrane transporter protein, a
periplasmic-exposed membrane adaptor protein, and an outer-
membrane channel protein. The Escherichia coli AcrAB-TolC and
the Pseudomonas aeruginosa MexAB-OprM complexes are well
characterized; besides, the resolution of the three-dimensional
structures of various components supported the model according
to which these efflux systems form a channel for the extrusion of
substrates/drugs from within the cell envelope back into the
external environment [9–13]. There are also a number of studies
suggesting that RND efflux systems play important roles in
bacterial pathogenesis, participating in colonization and persis-
tence of bacteria in the host, as well as in metal ion homeostasis
[14,15].
The significance of RND efflux systems in B. cenocepacia has been
only partially determined. We have previously identified 14 genes
encoding putative RND efflux pumps in the genome of B.
cenocepacia J2315 [16]. After the completion of the whole genome
sequence [5], two additional genes encoding RND pumps were
discovered and, very recently, a complete description of the
distribution of RND proteins within Burkholderia genus was
obtained [17]. We named the operons encoding the B. cenocepacia
RND efflux pumps RND-1 to RND-16 [18]. Most of these
operons comprise the membrane fusion protein, the RND pump,
and the outer membrane protein encoding genes.
Systematic measures of the role that RND efflux systems play in
Burkholderia can be obtained by deleting single or multiple rnd
operons and examining the genotype and phenotype of the
resulting mutants. However, B. cenocepacia strain J2315 is difficult to
manipulate genetically, in part due to its high level of antibiotic
resistance, which precludes the use of the most common selectable
markers for gene exchange. For this reason, also in our previous
work, we adopted a recently developed mutagenesis strategy [19]
to obtain rnd knockout mutants of B. cenocepacia J2315 [18]. The
mutagenesis strategy we employed has the advantage of generating
markerless deletions, making it possible to repeatedly use the same
antibiotic resistance cassette for engineering subsequent gene
deletions [19]. We successfully deleted three of these operons in B.
cenocepacia strain J2315, encoding the putative RND-1, RND-3,
and RND-4 transporters (namely BCAS0591-BCAS0593,
BCAL1674-BCAL1676, and BCAL2822-BCAL2820 genes) and
the corresponding inactivated strains were named D1, D3, and
D4. The mutant phenotypes demonstrated that RND-3 and
RND-4 contributed significantly to the antibiotic resistance of B.
cenocepacia [18].
The availability of rnd knockout mutants in B. cenocepacia J2315 is
a good starting point to further investigate the role of these efflux
systems not only in antibiotic resistance but also in other metabolic
pathways, including those relevant for pathogenesis. In fact,
multidrug transporter genes are frequently subjected to both local
and global regulation and are taking part in complex transcrip-
tional networks, which may be elucidated by transcriptome
analysis. Hence, the aim of this work was to analyze mutants of
B. cenocepacia J2315 impaired in rnd genes to assess their role in the
efflux of toxic compounds and physiology of B. cenocepacia by
comparing the transcriptome of mutants with that of the wild-type
strain using microarray analysis. We focused our attention on the
previously characterized D4 strain, as it showed an interesting
phenotype regarding drug resistance [18], and a novel mutant D9
[20], which was impaired in RND-9 operon (encoded by
BCAM1945-1947 genes). We chose D9 since it has been recently
shown by a combination of in silico analyses that BCAM1946
(RND-9) belongs to the HAE-1 family comprising proteins
responsible for the extrusion of antibiotics [17], and thus might
be able to pump out toxic compounds. However, the deep
phylogenetic analysis performed by Perrin et al. [17] showed also
that the BCAM1946 protein sequence joined the same cluster as
BCAL2821 (RND-4), even if they belong to different and distant
branches, and has a narrow phylogenetic distribution, in that its
orthologs are present only in a few Bcc species. This finding
suggests that RND-4 and RND-9 might be involved in different
physiologic processes. Further, this operon was chosen as
BCAM1947 gene was found to be over-expressed in the sputum
of CF patients [21] and because the whole operon shares amino
acid identity with the more known MexEF-OprN efflux system of
P. aeruginosa [22,23]. In fact, the product of BCAM1945 possesses a
38% amino acid sequence identity with OprN from P. aeruginosa,
while BCAM1946 has a 56% of identity with MexF and
BCAM1947 a 46% with MexE.
Hence, in this work we tried to shed some light on the role that
RND-4 and RND-9 might have in cell physiology and in
particular in the efflux of toxic compounds by analysing the
transcriptome of three mutants: D4, which was previously
described [18], D9 and D4–D9, single and double mutants
respectively. Microarray data were confirmed by qRT-PCR and
phenotypic experiments, as well as by Phenotype MicroArray
analysis.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. Bacteria were grown in Luria-Bertani (LB) broth (Difco),
with shaking at 200 rpm, or on LB agar, at 37uC. The
construction of mutants D4, D9 and D4–D9 has been described
in other papers [18,20].
MIC determination
Determination of MIC (Minimal Inhibitory Concentration) for
B. cenocepacia J2315 and the deleted mutants D9 and D4–D9 was
performed by streaking 1610
4 cells onto LB agar containing 2-fold
dilutions of different drugs. The MIC was defined as the lowest
drug concentration that prevented visible growth. The following
compounds were tested to determine the resistance profile:
aztreonam, ethidium bromide, chloramphenicol, gentamicin,
tobramicin, nalidixic acid, ciprofloxacin, levofloxacin, norfloxacin,
sparfloxacin, ampicillin, ceftazidime, erythromycin, meropenem,
piperacillin, kanamycin and trimethoprim. Plates were incubated
at 37uC for 3 days and growth was visually evaluated. The results
represent the average of three independent replicates. The
significance of MIC differences between the strains was assessed
using the Wilcoxon rank-sum test.
RNA purification and preparation for microarrays
For the microarray and qRT-PCR experiments, wild-type and
mutant B. cenocepacia J2315 cells were harvested by centrifugation
and transferred into sterile tubes. Total RNA was purified using
the RiboPure Bacteria Kit (Ambion) according to the manufac-
turer’s instructions. 1610
9 cells were used for three biological
replicates of each strain (J2315, D4, D9 and D4–D9).
A 1 hour incubation of each sample with DNase I (Ambion) was
used, following the manufacturer’s instructions. After extraction,
the RNA was concentrated using the LiCl method [24]. RNA
quality and concentration were assessed using the Agilent 2100
Bioanalyzer (Agilent) and agarose gel electrophoresis. All RNA
RND Pumps in B. cenocepacia
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10 mg of total RNA were used for labeling reactions. cDNA
generation and labeling was performed using the CyScribe Post-
Labeling kit (GE Healthcare) according to the manufacturer’s
instructions and including spike-in controls for quality control
(Agilent). cDNA was purified by ethanol precipitation and the
purification of the labeled cDNA was performed using the
CyScribe GFX purification kit. For the elution, water was used
instead of the buffer provided by the kit. The quantification of the
amount of generated cDNA and of Cy dye was performed with a
NanoDrop spectrophotometer.
Microarray hybridization and analysis
The microarrays used were 4644 K 60-mer arrays that contain
spots corresponding to all coding regions of B. cenocepacia J2315
genome (a total 7251 probes including duplicate probes for several
genes) and also probes corresponding to selected intergenic regions
(1489). Hybridization and washing were performed following the
‘‘Two-colour microarray based gene expression analysis’’ protocol
from Agilent, with the following exceptions: fragmentation buffer
was not used, 1 ml of a mixture of labeled oligonucleotides was
added, and the mixture of cDNA was incubated at 98uC for 3
minutes for denaturing. The hybridization buffer was from the
Gene Expression Hybridization kit. The microarrays were
scanned using a microarray scanner (G2565 BA, Agilent) and
the Scan Control software version A.7.0.3. Feb 2007 (Agilent).
The scan region was adjusted to 61621.6 mm and the scanning
resolution was set to 5 mm. The Extended Dynamic Range
function was switched on with 100% and 10% PMT gain settings.
The images were analysed with the Feature Extraction software
version 9.5.1. Feb 2007 (Agilent) and the FE protocol used was
GE2_v5_95_Feb07 with default settings. GeneSpring was used to
analyze gene expression data. The data were filtered based on
expression level changes of greater than 1.5-fold. Differentially
expressed genes were filtered on t-test p-value with a threshold of
0.05 (parametric test which does not assume the variances as
equal: Welch’s t-test) without multiple testing correction.
The software Blast2GO (version 2.3.4) [25] was used, with
default parameters, to obtain the functional annotation of the
differentially expressed transcripts as well as the related gene
ontology (GO) terms. Blast2GO was also used for GO functional
enrichment analysis of genes, by performing Fisher’s exact test
with robust false discovery rate (FDR) correction to obtain an
adjusted p-value between certain test gene groups and the whole
annotation.
Quantitative Real-Time PCR (qRT-PCR)
For each strain six unlinked genes were chosen for qRT-PCR
based on their differential expression pattern and annotation.
Three genes were chosen among the up-regulated ones and three
among the down-regulated ones. cDNA was synthesized using the
M-MLV Reverse Transcriptase (Promega) and using 2 mg of total
RNA as starting material. cDNA was precipitated, resuspended in
DEPC water and stored at 280uC. Primer sequences for
quantitative PCR are listed in Table 2. qRT-PCR reactions were
performed on a Rotor-Gene-6000 cycler (Corbett), using Quanti-
Fast SYBR Green PCR Kit (QIAGEN) according to the
manufacturer’s protocol except that 10 ml were used as a final
volume for each reaction. Cycling conditions were: 95uC for 5 min
(1 cycle), 95uC for 10 sec followed by 60uC for 30 sec (35 cycles). A
melting curve analysis was included at the end of each run. Each
sample was spotted in triplicate and a reference gene as well as
control samples without cDNA were included in each experiment.
The BCAM0166 (ndh) gene showed a stable expression in the
different strains and was used as reference gene. The comparative
Ct-method was used to determine the fold difference in gene
expression between the mutant strains and the wild-type.
The comparison of gene expression fold change, obtained both
by microarray analysis and qRT-PCR, was assessed by Pearson
correlation.
Swimming, biofilm and chemotaxis assays
For swimming assays, LB grown B. cenocepacia cultures
(A600 nm=1.0) were inoculated with a toothpick on ‘swimming
plates’ (1 g/l tryptone, 0.5 g/l yeast extract, 5 g/l NaCl, 3 g/l
agar noble) and incubated for 42 hours at 37uC. In this growth
medium bacteria can swim through the soft agar and produce a
halo. The diameter of the halo is a measure of the ability to swim.
Table 1. Strains and plasmids used in this work.
Strain or plasmid Relevant characteristics Source and/or reference
B. cenocepacia strains
J2315 CF clinical isolate G. Manno
D4 J2315 DBCAL2820-BCAL2822 [18]
D9 J2315 DBCAM1945-BCAM1948 [20]
D4–D9 J2315 DBCAM1945-BCAM1948 DBCAL2820-BCAL2822 [20]
E. coli strains
DH5a F
2 W80dlacZDM15 D(lacZYA-argF)U169 endA1 recA1 hsdR17(rK
2 mK
+) supE44 thi-1
DgyrA96 relA1
Laboratory stock
SY327 araD D(lac pro) argE(Am) recA56 nalA l pir,R i f
r M.A. Valvano
Plasmids
pGEM-T Easy Vector for PCR cloning, Amp
r Promega
pGPISce-I oriR6K, VTp
r, mob
+, containing the ISce-I restriction site, Tp
r M.A. Valvano
pRK2013 oricolE1, RK2 derivative, Kan
r, mob
+, tra
+,K a n
r M.A. Valvano
pDAISce-I pDA12 encoding the ISce-I homing endonuclease, Tet
r M.A. Valvano
Amp
r, ampicillin resistance; Kan
r, kanamycin resistance; Rif
r, rifampin resistance; Tet
r, tetracycline resistance; Tp
r, trimethoprim resistance.
doi:10.1371/journal.pone.0018902.t001
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pre-treated with mucin as described by Rose et al. [26]. Bacterial
cultures were grown in LB and diluted to A600=0.01; 150 mLo f
each strain was then placed into 96-well plates. The plates were
incubated at 37uC statically for 72 hours. After incubation, the
plates were washed three times with PBS to remove planktonic
growth. The remaining biofilm was fixed with methanol for
15 min. Once methanol was removed and plates were dried,
biofilms were stained with 1% Crystal Violet for 5 min. The stain
was removed by washing with water and plates were dried. Biofilm
thickness was measured by adding 33% glacial acetic acid and
taking an OD reading at 600 nm using an automated plate reader
[26].
The Congo red binding assay was carried out as previously
described, with slight modifications [27]. Briefly, bacteria were
grown on LB agar plates for 72 hours at 37uC. Colonies were
scraped off, suspended in 9 g/l NaCl and normalized to a
A600 nm=2.0. Cells from 1 ml of bacterial suspension were
harvested by centrifugation, suspended in 1 ml of Congo red
buffer [0.002% (w/v) Congo red dye (Sigma-Aldrich), 9 g/l NaCl]
and incubated at room temperature for 10 min. Samples were
then centrifuged for 5 min at 6000 rpm and the optical density at
500 nm wavelength (A500 nm) of the supernatant was measured.
The amount of Congo red dye not retained by the cells was
estimated by measuring the absorbance at A500 nm of the
supernatants. A500 nm levels are in inverse proportion to
exopolysaccharide and fimbrial structures production. The Congo
red binding of B. cenocepacia J2315 is defined as one hundred
percent binding.
For all the above described assays the average of the results
obtained from three independent experiments are reported with
standard deviation. The statistical significance of the observed
differences in mean invasion frequencies was determined by
calculating the p-values using the two-tailed Student t test for
unpaired data sets. p-values are reported in figure legends.
The Burkholderia chemotaxis assay was slightly modified from
Leungsakul et al., [28]. Cells in the exponential phase of growth or
heat-killed cells (negative control) were washed and resuspended in
drop assay medium (MSB containing 0.2% bacto-agar and
10 mM succinate as an energy source) and poured in Petri plates.
10 ml of 40% tryptone or 40 X LB or 20% yeast extract were
poured at the centre of each plate. 10 ml of 20% casamino acids
solution was used as a positive control. Heat-killed cells for
negative controls were prepared by autoclaving at 121uC for
30 min (control for non-chemotactic aggregation). No-substrate
negative controls were also used. The chemotactic response was
assessed after 18 hours.
Phenotype MicroArray (PM) tests
The four B. cenocepacia strains J2315, D4, D9 and D4–D9 were
tested on chemical sensitivity PM panels (PM11–PM20) (Biolog)
for 960 different conditions including several concentrations of a
wide variety of antibiotics, antimetabolites, heavy metals and other
inhibitors. A tetrazolium dye is used as a reporter of active
metabolism [29]. The reduction of the dye causes the formation of
a purple colour that is recorded by a CCD camera every 15 min
and provides quantitative and kinetic information about the
response of cells in the tested conditions.
The wild-type strain and the three mutants were grown
36 hours at 37uC on BUG agar (Biolog). A cellular suspension
in IF-0 (Biolog), whose density was adjusted to 80% transmittance
by a Biolog turbidimeter, was prepared for each strain. The
cellular suspension was diluted 13.64 times in IF-10 GN/GP
(Biolog), dye G (Biolog) was added, according to the Biolog
instructions, and used for plate inoculation. All PM plates were
incubated at 37uC in an Omnilog reader (Biolog). Readings were
recorded for 48 hours and data were analysed with Omilog-PM
software (release OM_PM_109 M) (Biolog).
The data from the Omnilog-PM software were filtered, using
the area of the kinetic curves as a parameter, then transferred to
Excel spreadsheets (Microsoft Corporation) and processed with
Bionumerics software (Applied Math) for principal-component
analysis (PCA) in order to establish the correlations between the
phenotype profiles of the strains.
The Omnilog-PM software also allowed the IC50 value to be
determined for each chemical tested (four concentrations of each
chemical were present in the plates from PM11 to PM20). IC50 is
expressed in well units and should be defined as the well or
fraction of a well at which a particular per-well parameter (i.e. the
area of the curve) is at half of its maximal value over a
concentration series. The half-maximal value most likely falls
between the per-well parametric values of two consecutive wells, in
which case, a fraction of a well is interpolated from the half-
maximal value (Biolog, personal communication).
Table 2. Primers used in this work.
Primer name Primer sequence
Bcal0114F 59-CGGATGCAGACCCAGAT-39
Bcal0114R 59-TGCAGGCTGTTCGTCAG-39
Bcal0135F 59-AACATGCCGAACCTCG-39
Bcal0135R 59-GCGATGATGTTCTCCTT-39
Bcal0140F 59-GTGCCTTACCAACTCT-39
Bcal0140R 59-CTGCTGCTGGCGAATG-39
Bcal0178F 59-TTGGGCGACTCAATGG-39
Bcal0178R 59-TTCGTGTATGGCGGAT-39
Bcal0520F 59-CCTGCTTCCATCGCTT-39
Bcal0520R 59-ACGCTCAACCCGCCCG-39
Bcal0566F 59-TCGTACACCAACAGCG-39
Bcal0566R 59-TGAGCCCCACCGTCGT-39
Bcal0577F 59-GCAGGTCAGCAGCAAC-39
Bcal0577R 59-CTGCGCGTAAGCCTTCT-39
Bcal1828F 59-GCATCAGGCGGCTTAC-39
Bcal1828R 59-CGCTTCGTCGGGAAAC-39
Bcal3152F 59-CTGCTGACGCTGTTGC-39
Bcal3152R 59-AACTCCAGCCCGCCGAC-39
Bcam0726F 59-GCAGCATGAACCACAC-39
Bcam0726R 59-CTGGCAAAGACGAACC-39
Bcam1484F 59-AGCATCCCGATCAGGT-39
Bcam1484R 59-GGCGAAGCGGAAGACG-39
Bcam2616F 59-CTGCACGACCTGCTGG-39
Bcam2616R 59-TGCCGGTCTGCTCCTG-39
Bcam0695F 59-CGGGGCGAGCGGGTTG-39
Bcam0695R 59-CCTCGGCGGCGTCGTG-39
Bcam0727F 59-AGGTCGGCGGGCAGGA-39
Bcam0727R 59-GCGGTACAGGTGTTCG-39
ndhF 59-GCGATCGGGCTGTACAAGTT-39
ndhR 59-AGTGGCTCAGCGACTGGAA-39
doi:10.1371/journal.pone.0018902.t002
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The raw microarray data (J2315 and D4) can be found in
ArrayExpress under the accession number E-MEXP-2999. The
raw data (J2315, D9 and D4–D9) can be found in ArrayExpress
under the accession number E-MEXP-2997.
Results
Resistance profile of rnd operon deleted mutants
In order to investigate the contribution of efflux pumps to
intrinsic drug resistance of B. cenocepacia J2315, we recently deleted
3 operons encoding the putative RND transporters RND-1, RND-
3, and RND-4 [18]. In this work we continued in the same
direction and analyzed the effect of the deletion of operon
encoding RND-9 efflux pump in the wild-type strain (D9 mutant),
as well as in the D4 strain (the double D4-D9 mutant) [20]. RND-
9, which is located on chromosome 2, comprises genes
BCAM1945-1947. It is noteworthy that in the D9 and D4-D9
mutant strains the BCAM1948 gene, encoding a MerR transcrip-
tional regulator and hypothesized to control the expression of
RND-9 operon, was inactivated, too [20].
The strains D9 and D4-D9 were tested for their susceptibility to
a number of drugs, in comparison to the wild-type strain B.
cenocepacia J2315. Strain D9 showed a 2-fold decrease of the MIC
value of aztreonam, ethidium bromide, tobramycin, levofloxacin,
and sparfloxacin in respect to the wild-type strain (Table 3). The
D4-D9 double mutant exhibited a 4 to 16-fold increase in drug
susceptibility to several of the antimicrobials tested: in particular, it
is more susceptible than the wild-type strain but comparable to the
D4 mutant when exposed to aztreonam, chloramphenicol,
ethidium bromide, gentamicin, tobramycin, and to different
fluoroquinolones, such as nalidixic acid, ciprofloxacin, levoflox-
acin, norfloxacin, sparfloxacin. Furthermore, the MIC for
nalidixic acid was 16-fold lower in D4–D9 than in J2315 and 4-
fold lower than in D4 (Table 3). The MIC values of other drugs
such as ampicillin, ceftazidime, meropenem, piperacillin, erythro-
mycin, and kanamycin were not altered in the D9 and in the D4–
D9 as compared to J2315 (data not shown).
The significance of MIC differences between the strains was
assessed using the Wilcoxon rank-sum test and all the differences
in antimicrobial susceptibility were statistically significant
(p,0.05).
Transcriptome analysis
In order to derive more information about the biological role of
RND transporters, transcriptome analysis was carried out by using
B. cenocepacia J2315, D4, D9 and D4-D9 strains. After a global
analysis of the microarray data obtained, different gene lists were
generated: genes induced in each mutant versus wild-type J2315,
down-regulated genes in each mutant strain versus J2315 and
differentially expressed genes overlapping in different mutants. A
complete list of the microarray data is reported in Table S1.
Overall, our analyses showed that 216 genes were differentially
expressed in D4 mutant in respect to the wild-type strain (Table
S1), corresponding to 3% of the total 7251 probes used in this
work. Among them, 32 encoded hypothetical proteins with
unknown function. 138 CDSs (64%) were up-regulated and 78
(36%) down-regulated (Table S1). 118 among the differentially
expressed genes in D4 mutant were located on chromosome 1
(55%), 55 on chromosome 2 (25%), and 42 (20%) on chromosome
3. 60 intergenic regions appeared to be differentially expressed in
D4 strain (39 up-regulated and 21 down-regulated, Table S1).
The D9 mutant showed 168 genes differentially expressed in
respect to the wild-type strain (Table S1). Among them, 43
encoded proteins with unknown function and 1 was not annotated.
61 CDSs (36%) were up-regulated and 107 down-regulated (64%)
(Table S1). 66 (40%) out of 168 differentially expressed genes were
located on chromosome 1, 73 (43%) on chromosome 2 and 29
(17%) on chromosome 3. Moreover, also 26 intergenic regions
resulted to be differentially expressed in this mutant (8 were up-
regulated and 18 down-regulated, Table S1).
In the case of the D4–D9 strain, 550 differentially expressed
genes (7.6% of the total probes) were detected. 257 of them (47%
of the differentially expressed genes) resulted to be up-regulated,
while 293 (53%) were down-regulated. 110 encoded proteins with
unknown function and 1 was not annotated (Table S1). 259 out of
550 differentially expressed genes were located on chromosome 1
(47%), 221 (40%) on chromosome 2, 67 (12%) on chromosome 3,
and 3 (less than 1%) on the plasmid. In the case of D4–D9 mutant,
also 84 intergenic regions resulted to be differentially expressed (31
up-regulated and 53 down-regulated) respect to the wild-type
strain.
A x
2 analysis of the distribution of the differentially expressed
genes on each chromosome was performed. In the case of D4 and
D9 strains, the results indicate that there is a significant correlation
between the number of differentially expressed genes and their
location on each chromosome, i.e. the proportion of differentially
expressed genes of each chromosome is correlating to the total
number of genes on each chromosome. This was not observed
with the D4-D9 double mutant.
Among the differentially expressed genes, it was possible to find
some similarities shared by our efflux pump deleted strains
(Figure 1). In particular, 33 genes resulted to be differentially
expressed with respect to the J2315 strain in all the mutants
described in this work (Table S1), with 24 of them being up-
regulated in all mutants, and 9 down-regulated (Figure 1). 84 genes
were differentially expressed in both D9 and D4–D9 mutants;
interestingly, only BCAM1697 resulted to be up-regulated in D9
and down-regulated in the double mutant, while the expression
profile of all the other genes was consistent in both strains, 63
being down-regulated and 21 up-regulated (Table S1, Figure 1).
As regarding D4 and D4-D9 mutants, 123 genes resulted to be
differentially expressed in both (44 down-regulated and 79 up-
regulated, all consistent in both strains, Table S1). These concepts
are clarified by the Venn diagram shown in Figure 1.
Major classes of B. cenocepacia genes with altered expression in
the mutant strains in respect to the wild-type were identified (see
Table 3. Antimicrobial susceptibilities (mg/ml) of
B. cenocepacia J2315, D9 and D4-D9 mutant strains.
Compound Strain
J2315 D4 D9 D4–D9
Aztreonam 2000 250 1000 250
Ethidium bromide 2000 125 1000 125
Chloramphenicol 4 1 4 1
Gentamicin 2000 1000 2000 1000
Tobramycin 1000 250 500 250
Nalidixic acid 16 4 16 1
Ciprofloxacin 8 2 8 2
Levofloxacin 4 0.5 2 0.5
Norfloxacin 32 8 32 8
Sparfloxacin 8 1 4 1
doi:10.1371/journal.pone.0018902.t003
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Using a functional enrichment analysis of genes (see supplemental
files: Tables S2, S3, S4, S5, S6, S7) it was possible to individuate
statistically significant functional categories that are over- or
under- represented in the differentially expressed gene-lists of the
efflux pump(s)-deleted mutant strains described in this work in
respect to the wild-type. The composition of these gene groups is
discussed in more detail below.
Flagellum mediated motility
Like many other microorganisms, B. cepacia complex bacteria are
motile and use complex protein structures called flagella. They
possess one or longer polar flagella responsible for swimming
motility. Many biological processes other than motility require the
presence of these structures, for example the production of biofilms,
adherence and invasion into host cells [30–32]. Flagella represent
one of the virulence factors which contribute to the development of
disease caused by these bacteria as shown by in vivo data [33]. They
have been described as a major factor contributing to host
inflammatory responses to bacteria due to the interaction of
bacterial flagellin with the Toll-like receptor 5 (TLR5) [34–36].
The production and assembly of these multi-component
structures involve more than 40 genes. In particular, members of
the Bcc express one of two types of flagellin that can be
distinguished by size (55 kDa for type I and 45 kDa for type II)
and restriction fragment length polymorphism (RFLP) patterns of
the fliC gene [37,38].
The results obtained from the comparison of the microarray
analysis of B. cenocepacia J2315 with D4, D9 and D4–D9 mutants
showed that a large proportion of the differentially expressed genes
were involved in flagellum assembly and motility (Table S1, Figures
S1, S4 and S5). In particular, D4 and D4-D9 mutants shared 26 up-
regulated flagellum-related genes (Table 4). Among them we found:
fliC (BCAL0114), encoding the major structural component of
flagellin, and BCAL0521 encoding the flagellar protein FliJ;
BCAL0140-BCAL0143, BCAL0523, BCAL0527, BCAL0561,
and BCAL3501, which code for flagellar biosynthesis proteins and
assembly; BCAL0113, BCAL0520, BCAL0567 and BCAL0577
encoding the hook-associated proteins. Moreover, some genes
belonging to the flagellar regulon master regulator flh (BCAL0124
and BCAL0125) were also over-expressed in these mutants
(Table 4). Lastly, some flagellar basal body Rod protein encoding
genes (BCAL0565, BCAL0566, BCAL0568, BCAL0569, and
BCAL3507) were up-regulated and shared by the two mutants, as
like as P- and L-ring proteins encoding ones (BCAL0570 and
BCAL0571) (Table 4).
In addition to the genes mentioned above, D4 mutant over-
expressed 12 additional flagellum-associated genes, four of which
coding for flagellar motor proteins (BCAL0524, BCAL3506,
BCAM0777, and BCAM0778) and other two for flagellar basal
body Rod protein (BCAL0564 and BCAM0987) (Table 4).
In contrast, the D9 mutant showed an enrichment of motility
related genes in the down-regulated gene list (BCAL0125,
BCAL0140, BCAL0142, BCAL0520, BCAL0522, BCAL0566,
BCAL0567, BCAL0568, BCAL0570, BCAL0571) (Table 4;
Figure S4).
Chemotaxis
The bacterial chemotaxis, which is mediated by two-component
systems, directs motile cells to favourable environments by
controlling phosphorylation of histidine kinase CheA and its
cognate response regulator CheY. Kinase activity is modulated by
the chemoreceptors, which are in turn regulated by both the
binding of chemoeffector and the level of methylation [39–41].
The expression of chemotaxis-related genes was strongly
influenced by the inactivation of the RND pumps. The D4 and
D4-D9 mutants shared 13 up-regulated chemotaxis-related genes
with respect to B. cenocepacia J2315 (Table 5). These genes encoded
MotA and MotB chemotaxis proteins (BCAL0126 and BCAL0127),
the chemotaxis two-component sensor regulator (BCAL0128), and
the sensor kinase CheA (BCAL0129). Moreover, the CheY2
(BCAL0135) and the CheZ (BCAL0136) encoding genes were up-
regulated in both deleted strains, as well as other four genes coding
for methyl-accepting chemotaxis proteins (BCAL0762, BCAM1424,
BCAM1804, and BCAM2689), plus one methyl-transferase
(BCAL0132), and one methyl-esterase (BCAL0134) (Table 5).
Furthermore, the D4 strain over-expressed other methyl-
accepting chemotaxis proteins: (BCAL0131, BCAM1503, and
BCAM2374), and BCAL0130 coding for the chemotaxis protein
CheW. D4–D9 strain also over-expressed BCAL1452, coding for a
methyl-accepting chemotaxis protein (Table 5). In contrast, in the
D9 mutant no chemotaxis-related genes were over-expressed,
while several of them were down-regulated (BCAL0129,
BCAL0133, BCAL0134, BCAL0136) (Table 5; Figure S4).
Down-regulated genes
The genes that showed a decreased expression profile in D4
and D4–D9 mutants belonged to many different functional
Figure 1. Differential gene regulation in the B. cenocepacia RND efflux mutants. The Venn diagram represents the differently expressed
genes (down-regulated on the left, up-regulated on the right) in each mutant with respect to the wild-type strain.
doi:10.1371/journal.pone.0018902.g001
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classes because only a small number of the down-regulated genes
were associated to each of many different metabolic processes.
The under-expressed genes were mainly involved in basal
metabolic processes of the cells, such as: macromolecule
metabolic process, biopolymer modification, regulation of
biosynthetic processes, regulation of cellular metabolic processes,
cellular respiration and protein transport (Table S1, Figure S2
and S6). Strikingly, the down-regulated genes in mutant D9
belonged both to the motility/adherence and chemotaxis classes
in contrast to the D4 and D4-D9 mutants which up-regulated this
class of genes (Table S1, Figure S3). It is quite possible that the
phenotype exhibited by the double mutant might be linked to D4
inactivation.
Table 4. Motility and adherence related genes differentially expressed in B. cenocepacia D4, D9 and D4–D9 mutants respect to
J2315.
Gene Description
Change in gene expression
(log2 fold change)
D4 vs J2315 D9 vs J2315 D4–D9 vs J2315
BCAL0113 flagellar hook-associated protein 4.89 - 3.75
BCAL0114 flagellin 7.76 - 4.97
BCAL0124 flagellar regulon master regulator subunit FlhD 3.59 - 1.52
BCAL0125 flagellar regulon master regulator subunit FlhC 3.31 21.16 2.03
BCAL0140 flagellar biosynthetic protein FlhB 3.78 21.88 2.63
BCAL0142 flagellar biosynthesis protein FlhF 3.25 20.82 2.28
BCAL0143 flagellar biosynthesis protein FlhG 4.53 - 1.85
BCAL0144 RNA polymerase sigma factor for flagellar 2.52 - 1.05
BCAL0520 putative flagellar hook-length control protein 2.98 21.21 2.31
BCAL0521 flagellar fliJ protein 3.23 - 1.88
BCAL0522 flagellum-specific ATP synthase 3.55 21.85 2.36
BCAL0523 flagellar assembly protein 3.73 - 2.16
BCAL0524 flagellar motor switch protein 2.03 - -
BCAL0525 flagellar M-ring protein 2.16 - -
BCAL0526 fliE flagellar hook-basal body complex protein FliE 2.19 - -
BCAL0527 flagellar protein 3.243 - 2.89
BCAL0561 putative flagella synthesis protein 2.23 - 1.38
BCAL0562 putative negative regulator of flagellin 2.81 - 1.34
BCAL0564 putative flagellar basal-body Rod protein 3.44 - -
BCAL0565 flagellar basal-body Rod protein 3.23 - 1.90
BCAL0566 putative basal-body Rod modification protein 4.88 21.21 2.56
BCAL0567 putative flagellar hook protein 4.18 21.31 2.36
BCAL0568 flagellar basal-body Rod protein 4.02 21.34 2.43
BCAL0569 flagellar basal-body Rod protein 4.10 - 2.35
BCAL0570 flagellar L-ring protein precursor 3.14 21.21 1.94
BCAL0571 flagellar P-ring protein precuror 2.85 20.61 1.83
BCAL0576 putative flagellar hook-associated protein 4.41 - -
BCAL0577 putative flagellar hook-associated protein 4.30 - 4.00
BCAL3501 flagellar biosynthetic protein 2.71 - 1.47
BCAL3503 flagellar biosynthetic protein 1.07 - -
BCAL3505 probable flagellar motor switch protein 3.13 - 1.83
BCAL3506 flagellar motor switch protein FliM 2.58 - -
BCAL3507 flagellar basal body-associated protein FliL 1.68 - 1.28
BCAM0777 putative flagellar motor proton channel 1.38 - -
BCAM0778 putative flagellar motor protein 1.73 - -
BCAM0987 putative flagellar basal body Rod protein 1.84 - -
BCAM2758 cblS, two-component regulatory system. sensor kinase protein 1.33 - -
BCAM2759 cblD, putative minor pilin and initiator 1.58 - -
doi:10.1371/journal.pone.0018902.t004
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Evaluation of the fold change correlation between qRT-PCR
experiments and microarray analysis was used to validate the over-
expression and under-expression ratios observed in the microarray
data (Table 6). 6 genes for each strain were chosen on the basis of
their putative function, expression patterns and statistical reliabil-
ity of the expression fold-change. The primers used are listed in
Table 2.
For the D4 mutant strain the genes coding for the following
proteins were chosen: the flagellin (BCAL0114), the chemotaxis
protein CheY2 (BCAL0135), the putative DNA methyltransferase
(BCAL0178), the putative flagellar hook-associated protein
(BCAL0577), the putative RNA polymerase sigma factor
(BCAL3152), and the putative HTH AraC family transcriptional
regulator (BCAM2616). For the D9 mutant the following were
selected: the flagellar biosynthetic protein FlhB (BCAL0140), the
putative flagellar hook-length control protein (BCAL0520), the
putative basal-body Rod modification protein (BCAL0566), two
conserved hypothetical proteins (BCAM0726 and BCAM0727),
and the putative response regulator BCAM1484 encoding genes.
For the double mutant D4–D9 the following genes were chosen:
BCAL0140, BCAL0520, BCAL0566, BCAL3152, the putative
fimbrial usher protein encoding gene (BCAL1828), and the
putative lipoprotein encoding gene BCAM0695. BCAM0166
(ndh, NADH dehydrogenase encoding gene) was used as internal
reference gene. Over-expression and under-expression ratios were
statistically consistent with the microarray findings and the overall
trend of gene expression was similar for both microarray and
qRT-PCR experiments for all the tested genes (Table 6), as shown
by Pearson correlation (data not shown). A good linear correlation
between both datasets was observed, with a coefficient of 0.85
(p,0.01) and a slope of 0.72.
Involvement of RND-4 and RND-9 efflux pumps in
flagella-dependent phenotypes
Microarray analysis suggested that the RND-4 and RND-9
efflux pumps could play opposite roles in flagellum-dependent
functions, like swimming and chemotaxis. To assess this
hypothesis, these phenotypes were analyzed in the wild-type and
in the RND-mutated strains, as described in Materials and
Methods.
Data obtained revealed that single mutants D4 and D9 showed
enhanced and reduced swimming motility with respect to the wild-
type, respectively. Moreover, the D4–D9 mutant showed a
swimming phenotype similar to that of the D4 mutant, suggesting
that at least for this phenotype, mutation of RND-4 dominates
over the mutation of RND-9 (Figure 2). These data were in full
agreement with the microarray analysis, showing that flagellum-
related genes are up-regulated in the D4 and D4–D9 mutants and
down-regulated in the D9 mutant (Table 4).
Concerning chemotaxis, we have performed preliminary
experiments using different attractant/repellents. The three
mutants and the wild-type showed the same positive chemotactic
phenotype versus casaminoacids and LB, and absence of
chemotactic response using toluene, aztreonam and chloram-
phenicol as repellents (data not shown).
It is known that in many bacteria flagella could play a role also
in adhesion and biofilm formation [42 and references therein].
Therefore, we performed a preliminary investigation about the
ability of the four strains to produce biofilm by using two
standard methods: adhesion to polyvinyl chloride microplates and
Congo red binding. The two methods gave comparable results
and, surprisingly, demonstrated that all the mutants showed
enhanced biofilm formation, with respect to the wild-type
(Figure 3).
Table 5. Chemotaxis related genes differentially expressed in B. cenocepacia D4, D9 and D4-D9 mutants respect to J2315.
Gene Description
Change in gene expression
(log2 fold change)
D4 vs J2315 D9 vs J2315 D4-D9 vs J2315
BCAL0126 chemotaxis protein MotA 3.43 - 2.27
BCAL0127 chemotaxis protein MotB 3.09 - 2.02
BCAL0128 chemotaxis two-component response regulator 3.32 - 2.44
BCAL0129 chemotaxis two-component sensor kinase CheA 3.52 -1.45 1.91
BCAL0130 chemotaxis protein CheW 2.99 - -
BCAL0131 methyl-accepting chemotaxis protein I 1.48 - -
BCAL0132 chemotaxis protein methyltransferase 3.48 - 1.49
BCAL0133 putative chemotaxis protein 3.33 -1.36 1.86
BCAL0134 chemotaxis protein-glutamate methylesterase 3.19 -0.83 1.73
BCAL0135 chemotaxis protein CheY2 2.55 - 1.34
BCAL0136 chemotaxis protein CheZ 2.48 -0.62 1.46
BCAL0762 putative methyl-accepting chemotaxis protein 1.96 - 1.58
BCAL1452 putative chemotaxis methyl-accepting membrane - - 0.69
BCAM1424 methyl-accepting chemotaxis protein 3.56 - 3.44
BCAM1503 putative methyl-accepting chemotaxis protein 1.87 - -
BCAM1804 methyl-accepting chemotaxis protein 3.29 - 2.93
BCAM2374 putative methyl-accepting chemotaxis protein 1.45 - -
BCAM2689 putative methyl-accepting chemotaxis protein 1.19 - 0.92
doi:10.1371/journal.pone.0018902.t005
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To check the effect of the deletion of RND-4 and/or RND-9
operons on the phenotype of the strain B. cenocepacia J2315, a
Phenotype MicroArray (PM) (Biolog) analysis was performed.
Phenotype MicroArray [29,43] is a technology allowing to
quantitatively measure thousands of cellular phenotypes all at
once. Ten different panels (PM11-PM20) that enable chemical
sensitivity tests for bacteria, were analyzed. A total of 240
chemicals at four different concentrations were tested out (a more
detailed information about the PM panels is available at http://
www.biolog.com). Data obtained are shown in Figure 4.
Principal component analysis (PCA) was applied to the PM data
to study the differences between the phenotype profiles of the four
strains in more detail (Figure 5). PCA separated the isolates into
two groups by the first component (which accounted for 76.6% of
phenotypic variation). One group housed wild-type and mutant
D9, and the other included mutants D4 and D4–D9. The second
component (which accounted for 12.7% of phenotypic variation)
provided a fairly good separation of strains D4 and D4–D9, and
did not allow the separation of wild-type and D9 mutant. These
results suggested that D9 mutant has a phenotype very similar to
that of the wild-type strain, while D4 is phenotypically different
from the wild-type and similar to the D4–D9 mutant. The
compounds under which the differences between the area of the
kinetic curves of the wild-type and mutant strains were over 15000
Biolog units in at least one of the concentrations for each chemical
assayed were selected and IC50 values are shown in Table S8. In
agreement with the inactivation procedure used in this work,
which makes use of a tetracycline resistance cassette, the three
mutants exhibited a decreased sensitivity to minocycline, an
antibiotic belonging to the tetracycline family. The mutants D4
and D4–D9 showed an increased sensitivity in respect to the wild-
type to different types of compounds: antibiotics, DNA inter-
calators, drugs, fungicides, detergents, toxic anions, ionophores,
uncouplers, oxidizing agents.
Discussion
In order to investigate the contribution of efflux pumps to
intrinsic drug resistance of B. cenocepacia J2315, we recently deleted
3 operons encoding the putative RND transporters RND-1
(BCAS0591-BCAS0593), RND-3 (BCAL1674-BCAL1676), and
RND-4 (BCAL2822-BCAL2820) [18]. We named the corre-
sponding inactivated strains D1, D3, and D4. The B. cenocepacia D3
and D4 mutants demonstrated increased sensitivity to inhibitory
compounds, suggesting an involvement of these proteins in the
intrinsic drug resistance of B. cenocepacia J2315. In contrast,
deletion of the RND-1 operon did not lead to detectable
phenotype alterations under the conditions assayed [18]. In this
work we continued in the same direction and analyzed the effect of
the deletion of operon encoding RND-9 efflux pump
(BCAM1945–1947 genes) in both the wild-type strain (thus
obtaining D9 mutant), and in the D4 strain (thus obtaining the
double D4–D9 mutant). Understanding the role of RND efflux
transporters in B. cenocepacia is fundamental to highlight their
involvement in drug resistance. Here, by integrating transcrip-
tomics, phenomics, and a set of different phenotypic assays, we
have expanded our previous work [18] and, in general, our
knowledge on the role of this clinically important protein family.
In particular, we have focused our attention on RND-4 and RND-
9 efflux pump encoding operons, characterizing the deleted
mutants D4, D9 and the double mutant D4–D9 by a combination
Table 6. Fold change obtained in D4, D9 and D4–D9 microarray compared to the fold change obtained by qRT-PCR.
Gene Description
Microarray
log2 fold change
qRT-PCR
log2 fold change
D4
BCAL0114 flagellin 7.76 7.47
BCAL0135 chemotaxis protein CheY2 2.55 0.62
BCAL0577 putative flagellar hook-associated protein 4.31 6.54
BCAL0178 putative DNA methyltransferase 23.11 210.45
BCAL3152 putative RNA polymerase sigma factor 24.37 22.23
BCAM2616 putative HTH AraC family transcriptional regulator 21.97 20.48
D9
BCAM0726 conserved hypothetical protein 1.71 2.38
BCAM0727 conserved hypothetical protein 1.24 2.93
BCAM1484 putative response regulator 0.58 0.19
BCAL0140 flagellar biosynthetic protein FlhB 21.88 21.14
BCAL0520 putative flagellar hook-length control protein 21.21 23.19
BCAL0566 putative basal-body Rod modification protein 21.21 22.86
D4–D9
BCAL0140 flagellar biosynthetic protein FlhB 2.63 2.28
BCAL0520 putative flagellar hook-length control protein 2.31 1.84
BCAL0566 putative basal-body Rod modification protein 2.56 3.03
BCAL1828 putative fimbrial usher protein 25.25 23.90
BCAL3152 putative RNA polymerase sigma factor 23.96 23.85
BCAM0695 putative lipoprotein 26.75 24.56
doi:10.1371/journal.pone.0018902.t006
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MicroArray (phenomic) procedure, a new technology that allows
to quantitatively measure thousands of cellular phenotypes all at
once, to check the ability of the wild-type and mutant strains to
pump out different toxic metabolites. This phenomic analysis
confirmed and strengthened previous data obtained by Buroni
et al. [18] on mutant D4, showing that RND-4 is involved in the
extrusion of a wide variety of compounds toxic for cell metabolism,
in agreement with antimicrobial susceptibilities of the mutant as
previously determined [18]. Similar results were obtained for the
double mutant D4–D9.
Concerning mutant D9, the scenario is more intriguing; indeed,
RND-9 seems to be only partially involved in drug efflux, showing
MIC values only 2-fold lower than the wild-type strain for a few
drugs, at least in our experimental conditions. These data are in
full agreement with Phenotype Microarray analysis, which
revealed that D9 mutant had a phenotype very similar to the
wild-type strain. This opens the intriguing question of the role that
this operon may play in vivo. However, since B. cenocepacia J2315
shows many genes involved in antibiotic resistance, many of which
might have (partially) overlapping functions, it is quite possible that
some of them might act in a synergistic fashion in determining the
Figure 2. Effect of RND-4 and RND-9 mutations on swimming motility. The average diameter of swimming halos from three different
experiments are plotted with standard deviations. Significantly differences with respect to J2315 are indicated by an * (p,0.01). Results are given in
percentage, considering B. cenocepacia J2315 (wt) swimming halo as 100%. The panel below the graph shows one representative experiment. J2315,
B. cenocepacia wild-type; D4, RND-4 mutant; D9, RND-9 mutant; D4-D9, RND4-RND9 mutant.
doi:10.1371/journal.pone.0018902.g002
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decrease in MIC in the D9 deletion mutant is a proof that this
pump may be involved in resistance to these antibiotics. Besides, as
shown by Perrin et al. [17], BCAM1946 protein sequence (which
appertains to RND-9 operon) belongs to the same phylogenetic
cluster embedding BCAL2821 (which is part of RND-4), but to a
different and distant branch, very close to the widely distributed
RND-10 (BCAM2549-51); lastly, the phylogenetic distribution of
RND-9 is very narrow, in that its orthologs were shown to be
present only in a few Bcc species [17]. This might suggest that the
absence of RND-9 function in D9 mutant could be replaced by
other efflux systems, belonging to the same and/or to different
phylogenetic clusters. An alternative, even though not mutually
exclusive possibility, is that since the toxic compounds tested are
not metabolic intermediates produced by Burkholderia cells, RND-9
is involved in the efflux of toxic (or even not-toxic) molecules
produced by the microorganism under different physiological
conditions.
The phenotypic similarity shared by mutants D4 and D4–D9
was confirmed also at the molecular level by the transcriptome
analysis. Indeed, the microarray results showed that D4 and D4–
D9 mutants have a similar expression profile, in particular motility
and chemotaxis-related genes appear to be up-regulated in both
strains. In contrast, the same genes are down-regulated or not
differentially expressed in D9 mutant. Most differentially regulated
genes of the single mutants were also differentially regulated in the
double mutant, and for the most part in the same directionality.
This illustrated how the double mutant displays a combined,
additive expression profile of both single mutants and one would
therefore expect to see an additive phenotype. The overall trend of
gene expression was confirmed by qRT-PCR experiments by
Pearson correlation, indicating that the microarray for B.
cenocepacia is reliable to assess gene expression changes in this
strain as has been shown in previous studies [21,44]. Moreover,
data are consistent with the observations from the motility assays,
in which the D4 and the double mutant show enhanced swimming
motility with respect to the wild-type, in contrast with mutant D9
where this phenomenon is reduced. Moreover, D4 has 12 more
up-regulated genes involved in motility than D4–D9, as reported
in Table 4. This could be an explanation to the fact that this
mutant is more motile than the double mutant D4–D9 (Fig. 2). In
this view, it seems that D9 mutation is able to partially suppress the
effects of the D4 mutation, at least for what concerns swimming.
Regarding chemotaxis, despite the differences observed in the
microarray analysis, the three mutants showed the same
chemotactic phenotype at least under our experimental conditions.
It is possible that differences in chemotaxis might be appreciated
by the use of specific attractant or repellent molecules. However, it
is not trivial to identify such specific compounds and further
studies should be performed in order to address this point.
These unexpected and interesting results strongly suggest that
the biological role of the RND-4 and RND-9 efflux pumps might
not be restricted to the sole transport of toxic (and/or not toxic)
compounds, but also that their function might be related to
motility and/or chemotaxis. To the best of our knowledge, this is
the second time that the effect of RND efflux pumps mutation on
motility-related phenotypes has been described. Indeed, the
absence of RND components AcrB or TolC in Salmonella enterica
caused widespread repression of chemotaxis and motility genes in
these mutants, and for acrB mutant this was associated with
decreased motility [45]. However, why the deletion of an efflux
pump should have a fallout on bacterial motility and chemotaxis
remains an open question. It is conceivable that the cytoplasmic
accumulation of efflux pump-specific metabolites (different for
each mutant) could act as signals triggering opposite behavioural
response in the two mutants. For instance, we have recently shown
that RND-4 contributes to the transport of N-acyl homoserine
lactone (AHLs) as we found a reduced accumulation of AHLs
quorum sensing (QS) signal molecules in the growth medium of
D4 mutant [18]. Actually, the D4 and D4/D9 mutant produce
about 30% less AHLs than the wild-type, while D9 produces
almost the same level of acyl-HSL as the wild-type ([18] and
Figure S7). In accordance with the low impact of D4 and D9
mutations on AHLs production, only few genes known to be AHL-
regulated are also differentially regulated in our microarray
analysis (Table S9). Among these, none can be directly related
to chemotaxis or biofilm formation, and only BCAL0562 and
BCAL3506 could be related to flagella. Overall, these observations
suggest that it is unlikely that the phenotype of the D4, D9 and
D4–D9 mutants is due to an unbalance in AHLs import/export
rates. However, it cannot be ruled out that other molecules acting
as metabolic signals could accumulate in the D4, D9 and D4–D9
mutants and account for the motility and biofilm phenotypes of
these strains. Another possible explanation for the biological
significance of the phenotype exhibited by D4 and D4–D9 strains
might rely on the assumption that: i) the bacterial cell can ‘‘sense’’
the concentration of toxic compounds outside and/or inside the
Figure 3. Effect of RND-4 and RND-9 mutations on biofilm
formation. (A) Adhesion to polyvinyl chloride mitrotiter plates
measured by crystal violet staining. (B) Congo red dye binding ability.
In both cases, results are given as a percentage, considering
B. cenocepacia J2315 (wild-type) as 100%. The mean of three different
experiments with standard deviation is reported. Significantly differ-
ences with respect to J2315 are indicated by an * (p,0.01). J2315,
B. cenocepacia wild-type; D4, RND-4 mutant; D9, RND-9 mutant; D4–D9,
RND4-RND9 mutant.
doi:10.1371/journal.pone.0018902.g003
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concentration of toxic compound(s) by activating the efflux pump
systems responsible for the extrusion of that compound(s).
Accordingly, we can speculate that in the absence (such as in
D4 and D4–D9 mutants) of these systems, the cell might somehow
bypass this defect by increasing the ability to move in the
environment in order to ‘‘escape’’ and to explore spaces and
niches where the concentration of the toxic compounds is lower.
In other words, the increased ability to move might represent a
sort of ‘‘indirect protection’’ of the cell towards toxic compounds.
Since in many bacteria flagellum could play a role in biofilm
formation, the different regulation of flagellum-related genes in D4
and D9 prompted us to speculate that these strains might also have
opposite biofilm phenotypes. Therefore, we performed prelimi-
nary experiments to investigate the biofilm formation ability of the
wild-type and of the three mutants. Results showed, surprisingly,
that all the mutants had an enhancement of biofilm formation with
respect to the wild-type. Therefore, differences in flagella
expression in the D4 and D9 strains, with respect to the wild-
type, play a minor role in biofilm formation, at least under our
experimental conditions. The increased biofilm production of the
RND-mutants was unexpected since we did not identify genes
obviously involved in biofilm formation among the 33 having the
same expression pattern in the three microarray experiments
(Figure 1 and Table S1). Actually, biofilm formation is a complex
pleiotropic phenotype, strongly dependent upon experimental
conditions and growth media [46,47]. Therefore, it is not easy to
correlate the microarray data derived from planktonic cultures
with the increased biofilm production of the RND-mutants, with
respect to the wild-type. However, 19 out of the 24 genes up-
regulated in all the microarray experiments, are phage-related
genes (located in the region spanning from ORFs BCAS0506 to
BCAS0554; Table S1, Figure 1). Over-expression of phage-related
genes in sessile cells compared with planktonic cells and/or
increased expression in response to stress has been observed in
several species [47 and references therein]. Bacterial stress
response can increase the mobility of bacteriophages, and it has
been proposed that prophage production may play a role in
generating genetic diversity in the biofilm [47 and references
therein]. It is tempting to speculate that cytoplasmic accumulation
of toxic metabolites and/or metabolic signals due to the lack of
RND-4 and/or RND-9 efflux pumps could produce a general
stress response triggering the expression of genes involved in
biofilm formation. This finding stimulates future studies on the
role played by RND pumps in the efflux of endogenously
produced molecules potentially involved in virulence and host
colonization (e.g. biofilm matrix components, biologically active
secondary metabolites, signal molecules), besides their role in drug
resistance. The biofilm experiment also showed that D9 produces
less biofilm than D4 and D4–D9. This result might be explained,
at least in part, by the observation that, besides flagella genes, also
cellulose biosynthetic genes (ORFs BCAL1391 and BCAL1395,
Table S1) were up- and down-regulated in the D4 and D9
mutants, respectively, and the D9 showed down-regulation of
fimbrial genes (ORFs BCAL0959 and BCAL2636, Table S1).
The different expression of genes involved in pathways strongly
related to virulence is a first step towards a better understanding of
B. cenocepacia pathogenesis. A relevant point is that inactivation of
efflux pumps enhances biofilm formation and, sometimes, motility.
If this is true also in the host, the use of efflux pump inhibitors
Figure 4. The Phenotype Microarray profile of B. cenocepacia J2315 and the RND mutants. Metabolic plates (from PM 11 to PM20)
representing the growth of the three B. cenocepacia mutant strains D4, D9 and D4–D9 versus the wild-type strain J2315, in the presence of toxic
compounds is shown.
doi:10.1371/journal.pone.0018902.g004
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the other side, it could promote biofilm formation and chronic
infection. More detailed study on the effect of RND efflux pumps
in virulence-related phenotype and chronic infection are strongly
desirable.
In the future the construction of a multiple inactivated strain
will be helpful both to understand if the lack of these proteins may
affect pathways important for the life of the pathogen and,
hopefully, to construct an attenuated strain, for the design of a
suitable vaccine.
Supporting Information
Figure S1 Pie chart representing Gene Ontology (GO)
terms distribution in B. cenocepacia D4 mutant up-
regulated genes. Representation of the functional classes at the
different nodes of one level in GO term association analysis.
(TIF)
Figure S2 Pie chart representing Gene Ontology (GO)
terms distribution in B. cenocepacia D4 mutant down-
regulated genes. Representation of functional classes at the
different nodes of one level in GO term association analysis.
(TIF)
Figure S3 Pie chart representing Gene Ontology (GO)
terms distribution in B. cenocepacia D9 mutant up-
regulated genes. Representation of functional classes at the
different nodes of one level in GO term association analysis.
(TIF)
Figure S4 Pie chart representing Gene Ontology (GO)
terms distribution in B. cenocepacia D9 mutant down-
regulated genes. Representation of functional classes at the
different nodes of one level in GO term association analysis.
(TIF)
Figure S5 Pie chart representing Gene Ontology (GO)
terms distribution in B. cenocepacia D4–D9 mutant up-
regulated genes. Representation of functional classes at the
different nodes of one level in GO term association analysis.
(TIF)
Figure S6 Pie chart representing Gene Ontology (GO)
terms distribution in B. cenocepacia D4–D9 mutant
down-regulated genes. Representation of functional classes at
the different nodes of one level in GO term association analysis.
(TIF)
Figure S7 Evaluation of AHLs accumulation in the
growth medium of B. cenocepacia J2315 and RND
mutants. AHL measurement was carried out using E. coli
(pSCR1) as described by Buroni et al. [18]. AHL was extracted
from spent supernatants, AHL levels were measured with a
volume of extract corresponding to 10
9 CFU. Values of AHL
accumulated in the supernatant are in percentage in relation to the
wild-type strain. The experiments were performed in triplicate
giving comparable results. Significantly differences with respect to
J2315 are indicated by an * (p,0.05). J2315, B. cenocepacia wild-
type; D4, RND-4 mutant; D9, RND-9 mutant; D4–D9, RND4-
RND9 mutant.
(TIFF)
Figure 5. Principal component analysis of phenotype microarrays profiles of B. cenocepacia J2315 and D4, D9, D4–D9 mutants,
obtained from an analysis of 960 chemical sensitivity tests (PM11-PM20). The figure shows the four strains (J2315, D4, D9, D4–D9) and the
phenotypical tests plotted in an X-Y diagram corresponding to the first two components.
doi:10.1371/journal.pone.0018902.g005
RND Pumps in B. cenocepacia
PLoS ONE | www.plosone.org 13 April 2011 | Volume 6 | Issue 4 | e18902Table S1 Complete list of genes up- or down-regulated
in B. cenocepacia strains D4, D9, D4–D9 versus J2315
deriving from the microarray analysis.
(DOC)
Table S2 Gene Ontology (GO) terms functional enrich-
ment analysis showing the over or under-representation
of up-regulated genes of mutant D4 in comparison to
B. cenocepacia J2315 whole genome functional annota-
tion. Only GO terms over- or under- represented with an
associated
p-value ,0.05 are shown.
(DOC)
Table S3 Gene Ontology (GO) terms functional enrich-
ment analysis showing the over or under-representation
ofdown-regulated genesofmutantD4incomparisontoB.
cenocepacia J2315 whole genome functional annotation.
(DOC)
Table S4 Gene Ontology (GO) terms functional enrich-
ment analysis showing the over or under-representation
of up-regulated genes of mutant D9 in comparison to
B. cenocepacia J2315 whole genome functional annota-
tion. Only GO terms over- or under- represented with an
associated p-value ,0.05 are shown.
(DOC)
Table S5 Gene Ontology (GO) terms functional enrich-
ment analysis showing the over or under-representation
of down-regulated genes of mutant D9 in comparison to
B. cenocepacia J2315 whole genome functional annota-
tion. Only GO terms over- or under- represented with an
associated p-value ,0.05 are shown.
(DOC)
Table S6 Gene Ontology (GO) terms functional enrich-
ment analysis showing the over or under-representation
of up-regulated genes of mutant D4-D9 in comparison to
B. cenocepacia J2315 whole genome functional annota-
tion. Only GO terms over- or under- represented with an
associated p-value ,0.05 are shown.
(DOC)
Table S7 Gene Ontology (GO) terms functional enrich-
ment analysis showing the over or under-representation
of down-regulated genes of mutant D4–D9 in compari-
son to B. cenocepacia J2315 whole genome functional
annotation. Only GO terms over- or under- represented with an
associated p-value ,0.05 are shown.
(DOC)
Table S8 Schematic representation of data obtained
from PM (from PM11 to PM20) analyses of B. cenocepa-
cia strain J2315, D4, D9 and D4–D9. *IC50 was calculated
on the basis of the kinetic curves obtained on the four different
concentrations of each chemical compound and it was defined as
the well or fraction of a well at which the area of kinetic curve is at
half of its maximal value over the concentration series. **IC50 is
reported only for compounds under which the difference between
the areas of the kinetic curves of wild-type and mutant strain was
over 15000 units in at least one of the concentrations tested.
(DOC)
Table S9 List of genes differentially regulated in
B.cenocepaciastrainsD4,D9,D4–D9versus J2315known
to be also controlled by AHL-based quorum sensing.
(DOC)
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